Woodline Partners’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Buy |
781,222
+566
| +0.1% | +$1.55K | 0.01% | 714 |
|
|
2025
Q1 | $1.31M | Buy |
780,656
+90,515
| +13% | +$152K | 0.01% | 729 |
|
|
2024
Q4 | $1.12M | Buy |
690,141
+2,320
| +0.3% | +$3.78K | 0.01% | 738 |
|
|
2024
Q3 | $2.86M | Buy |
687,821
+3,627
| +0.5% | +$15.1K | 0.02% | 440 |
|
|
2024
Q2 | $3.74M | Sell |
684,194
-214,856
| -24% | -$1.17M | 0.04% | 365 |
|
|
2024
Q1 | $8.99M | Buy |
899,050
+214,856
| +31% | +$2.15M | 0.08% | 285 |
|
|
2023
Q4 | $2.79M | Buy |
684,194
+330,866
| +94% | +$1.35M | 0.03% | 359 |
|
|
2023
Q3 | $1.37M | Buy |
353,328
+3,328
| +1% | +$12.9K | 0.02% | 422 |
|
|
2023
Q2 | $2.09M | Sell |
350,000
-350,000
| -50% | -$2.09M | 0.02% | 421 |
|
|
2023
Q1 | $2.29M | Buy |
700,000
+76,734
| +12% | +$251K | 0.03% | 401 |
|
|
2022
Q4 | $2.46M | Sell |
623,266
-593,650
| -49% | -$2.34M | 0.03% | 450 |
|
|
2022
Q3 | $7.3M | Sell |
1,216,916
-106,317
| -8% | -$638K | 0.1% | 237 |
|
|
2022
Q2 | $8.51M | Sell |
1,323,233
-228,707
| -15% | -$1.47M | 0.13% | 194 |
|
|
2022
Q1 | $12.8M | Buy |
1,551,940
+1,069,234
| +222% | +$8.83M | 0.21% | 148 |
|
|
2021
Q4 | $7.47M | Buy |
482,706
+62,839
| +15% | +$973K | 0.11% | 231 |
|
|
2021
Q3 | $9.46M | Buy |
419,867
+9,019
| +2% | +$203K | 0.15% | 169 |
|
|
2021
Q2 | $8.08M | Buy |
410,848
+8,854
| +2% | +$174K | 0.15% | 160 |
|
|
2021
Q1 | $13.5M | Buy |
+401,994
| New | +$13.5M | 0.3% | 91 |
|